Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Academy of Dermatology
Pharma
In year 2 under new CEO, troubled Leo Pharma makes progress
Leo its touting progress on its turnaround. The 115-year-old company cut its operating costs by 14% in 2023 while increasing its revenues by 7%.
Kevin Dunleavy
Mar 12, 2024 1:47pm
BI's bold 'Unwearable Collection' spotlights rare skin disease
Apr 1, 2022 8:05am
Sun uses the journey as a metaphor in demo exhibition booth
Mar 31, 2022 8:00am
Incyte rolled out 52-week data on Opzelura in vitiligo
Mar 26, 2022 10:40am
AbbVie's Skyrizi bests Cosentyx in head-to-head psoriasis trial
Jun 15, 2020 10:47am
Latest field facing a payer squeeze? New, better psoriasis meds
Feb 21, 2018 11:15am
